Alcohol Free, Sulfate Free, Paraben Free
A concentration reported in one paper should be treated as a starting point, not as a universal protocol
Injectable GLP-1 receptor agonists have no known direct pharmacokinetic interaction with levothyroxine, but they do slow gastric emptying, which theoretically could affect the absorption kinetics of oral medications
Large cardiovascular outcome trials involving injectable GLP-1 RAs such as liraglutide, semaglutide, dulaglutide, and albiglutide have shown GLP-1 RAs are associated with consistent reduction in major adverse cardiovascular events (MACE) and progression of renal disease [5,6,7,8,9]